James C. Mullen, CEO & President at BIOGEN IDEC INC. (BIIB), sold 440,500 shares at $59.97 ($26.4M) on 2010-03-19, disclosed to the SEC on 2010-03-23.
Scheduled sale ($26.4M) by CEO & President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.97 | 334,221 | $20.0M | 75.9% |
| 2 | $59.95 | 106,279 | $6.4M | 24.1% |
| Total | $59.97 avg | 440,500 | $26.4M | 100% |
| Filing → |
| EDIT | BUY | 2021-03-04 | $1.2M | — | Filing → |
| EDIT | BUY | 2018-05-22 | $380K | — | Filing → |
| PODD | BUY | 2017-11-14 | $169K | — | Filing → |